The coding capacity of SARS-CoV-2 Y Finkel, O Mizrahi, A Nachshon, S Weingarten-Gabbay, D Morgenstern, ... Nature 589 (7840), 125-130, 2021 | 609 | 2021 |
SARS-CoV-2 uses a multipronged strategy to impede host protein synthesis Y Finkel, A Gluck, A Nachshon, R Winkler, T Fisher, B Rozman, O Mizrahi, ... Nature 594 (7862), 240-245, 2021 | 215 | 2021 |
Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs S Weingarten-Gabbay, S Klaeger, S Sarkizova, LR Pearlman, DY Chen, ... Cell 184 (15), 3962-3980. e17, 2021 | 139* | 2021 |
Parsing the role of NSP1 in SARS-CoV-2 infection T Fisher, A Gluck, K Narayanan, M Kuroda, A Nachshon, JC Hsu, ... Cell reports 39 (11), 2022 | 53 | 2022 |
Conflicting and ambiguous names of overlapping ORFs in the SARS-CoV-2 genome: A homology-based resolution I Jungreis, CW Nelson, Z Ardern, Y Finkel, NJ Krogan, K Sato, J Ziebuhr, ... Virology 558, 145-151, 2021 | 51 | 2021 |
Genome-wide CRISPR screens identify GATA6 as a proviral host factor for SARS-CoV-2 via modulation of ACE2 M Israeli, Y Finkel, Y Yahalom-Ronen, N Paran, T Chitlaru, O Israeli, ... Nature communications 13 (1), 2237, 2022 | 36 | 2022 |
Comprehensive annotations of human herpesvirus 6A and 6B genomes reveal novel and conserved genomic features Y Finkel, D Schmiedel, J Tai-Schmiedel, A Nachshon, R Winkler, ... Elife 9, e50960, 2020 | 34 | 2020 |
Viral short ORFs and their possible functions Y Finkel, N Stern‐Ginossar, M Schwartz Proteomics 18 (10), 1700255, 2018 | 21 | 2018 |
MGH COVID-19 Collection & Processing Team S Weingarten-Gabbay, S Klaeger, S Sarkizova, LR Pearlman, DY Chen, ... Bhardwaj N, 3962-3980, 2021 | 8 | 2021 |
A virally encoded high-resolution screen of cytomegalovirus dependencies Y Finkel, A Nachshon, E Aharon, T Arazi, E Simonovsky, M Dobešová, ... Nature, 1-8, 2024 | 2* | 2024 |
High-throughput discovery of regulatory effector domains in human RNA-binding proteins AR Thurm, Y Finkel, C Andrews, XS Cai, C Benko, L Bintu bioRxiv, 2024.07. 19.604317, 2024 | | 2024 |